ADAM10 mediates shedding of carbonic anhydrase IX ectodomain non‑redundantly to ADAM17

Oncol Rep. 2023 Feb;49(2):27. doi: 10.3892/or.2022.8464. Epub 2022 Dec 16.

Abstract

Carbonic anhydrase IX (CA IX) is a transmembrane enzyme participating in adaptive responses of tumors to hypoxia and acidosis. CA IX regulates pH, facilitates metabolic reprogramming, and supports migration, invasion and metastasis of cancer cells. Extracellular domain (ECD) of CA IX can be shed to medium and body fluids by a disintegrin and metalloproteinase (ADAM) 17. Here we show for the first time that CA IX ECD shedding can be also executed by ADAM10, a close relative of ADAM17, via an overlapping cleavage site in the stalk region of CA IX connecting its exofacial catalytic site with the transmembrane region. This finding is supported by biochemical evidence using recombinant human ADAM10 protein, colocalization of ADAM10 with CA IX, ectopic expression of a dominant‑negative mutant of ADAM10 and RNA interference‑mediated suppression of ADAM10. Induction of the CA IX ECD cleavage with ADAM17 and/or ADAM10 activators revealed their additive effect. Similarly, additive effect was observed with an ADAM17‑inhibiting antibody and an ADAM10‑preferential inhibitor GI254023X. These data indicated that ADAM10 is a CA IX sheddase acting on CA IX non‑redundantly to ADAM17.

Keywords: ADAM10; ADAM17; cancer; carbonic anhydrase IX; ectodomain shedding; internalization.

MeSH terms

  • ADAM Proteins* / chemistry
  • ADAM Proteins* / metabolism
  • ADAM10 Protein / chemistry
  • ADAM10 Protein / metabolism
  • ADAM17 Protein / chemistry
  • ADAM17 Protein / metabolism
  • Carbonic Anhydrase IX* / chemistry
  • Carbonic Anhydrase IX* / metabolism
  • Humans
  • Membrane Proteins / metabolism
  • Neoplasms / metabolism

Substances

  • ADAM Proteins
  • ADAM10 Protein
  • ADAM10 protein, human
  • ADAM17 Protein
  • ADAM17 protein, human
  • Carbonic Anhydrase IX
  • Membrane Proteins

Grants and funding

The present study was supported by the Slovak Scientific Grant Agency (grant nos. VEGA 2/0074/20 and VEGA 2/0076/20), the Research & Developmental Support Agency (grant nos. APVV-15-0697 and APVV-19-0098) and the George Schwab and Leona Lauder Foundation.